Multiple Sclerosis, Relapsing-Remitting trials recruiting in Illinois

All Multiple Sclerosis, Relapsing-Remitting trials nationally

Cities in Illinois

Recruiting trials in Illinois

• Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
  NCT06390930 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• Intermittent Hypoxia in Persons With Multiple Sclerosis
  NCT06276634 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
  NCT06408259 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago